Answers are grounded in this paper and cite their sources.
Interview explores monoclonal antibodies' impact on treatment and prevention in high-risk populations, suggesting significant benefits.
Interview with Dr. Anthony Fauci on the use of monoclonal antibodies in the context of emerging infectious diseases. (09:25)Download Research advances could facilitate use of monoclonal antibodies for emerging infectious diseases — in treatment of infected individuals, targeted prophylaxis to protect high-risk individuals, and targeted prophylaxis to interrupt transmission in average-risk populations.
No takes yet. Share an insight, caveat, or question.
Marston et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: